Remdesivir IP Impurity C
Remdesivir IP Impurity C or (S)-2-ethylbutyl 2-(((S)-(((3aR,4R,6R,6aR)-6-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-6-cyano-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate,used to treat acute respiratory syndrome coronavirus 2 and inhibited by a class of drugs known as nucleoside analogues.
Additional information on Remdesivir IP Impurity C
VE008311
N/A
C30H39N6O8P
642.64 g/mol
Remdesivir
(S)-2-ethylbutyl 2-(((S)-(((3aR, 4R, 6R, 6aR)-6-(4-aminopyrrolo[2, 1-f][1, 2, 4]triazin-7-yl)-6-cyano-2, 2-dimethyltetrahydrofuro[3, 4-d][1, 3]dioxol-4-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
N/A
Frediansyah, Andri, et al. “Remdesivir and Its Antiviral Activity against COVID-19: A Systematic Review.” Clinical Epidemiology and Global Health, vol. 9, Jan. 2021, pp. 123–27, https://doi.org/10.1016/j.cegh.2020.07.011. ?
In-stock
